Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | CRL | UNH |
|---|
| Close | 273.41 | 375.26 |
| Market Cap | $13.1B | $337B |
| 1M | −4.62% | −5.15% |
| P/E (TTM) | — | 23.9 |
| Forward P/E | 24.2 | 19.7 |
| P/E 5-Yr Percentile | — | 53 |
| P/S | 3.3 | 0.8 |
| P/B | 4.6 | 3.2 |
| Dividend Yield | — | 1.37% |
| Latest Quarter Revenue | $1.0B | $112B |
| Revenue YoY | −2.7% | +0.4% |
| Gross Margin | — | 88.1% |
| Latest Quarter EPS | -0.03 | 6.04 |
| Avg Post-Earnings Move | ±1.8% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 2.89% |
| 90-Day Net Insider Buying | −$42.6M | −$0.66M |
CRL · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
